These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12379078)

  • 1. The effect of HFE genotypes on measurements of iron overload.
    Koziol JA; Felitti VJ; Beutler E
    Ann Intern Med; 2002 Oct; 137(8):700-1. PubMed ID: 12379078
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
    Beutler E; Felitti V; Gelbart T; Ho N
    Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic strategy for iron overload in adults (excluding hematologic iron overload)].
    Brissot P
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B88-9. PubMed ID: 10891770
    [No Abstract]   [Full Text] [Related]  

  • 7. [Practical use of genetic markers other than C282Y in iron overload disorders].
    Brissot P
    Gastroenterol Clin Biol; 2002 Nov; 26(11):991-3. PubMed ID: 12483130
    [No Abstract]   [Full Text] [Related]  

  • 8. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism.
    Gómez-Llorente C; Miranda-León MT; Blanco S; Gandia-Pla S; Gómez-Capilla JA; Fárez-Vidal ME
    Ann Hematol; 2005 Oct; 84(10):650-5. PubMed ID: 15986199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder.
    Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS
    Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.
    Fonseca PFS; Cançado RD; Naoum FA; Dinardo CL; Fonseca GHH; Gualandro SFM; Krieger JE; Pereira AC; Brissot P; Santos PCJL
    BMC Med Genet; 2018 Jan; 19(1):3. PubMed ID: 29301508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C; Opazo S; Murga MJ; Martínez-Castro P
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
    Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values.
    Castiella A; Alustiza JM; Zapata E; Emparanza JI; Otazua P; Zubiaurre L; Aguirre A
    Ann Hematol; 2012 Jun; 91(6):961. PubMed ID: 21971668
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
    Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC40A1-R178G mutation and ferroportin disease.
    Speletas M; Onoufriadis E; Kioumi A; Germenis AE
    J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.